An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial ...
TTI-109 delivered TTI-101-equivalent exposure with improved tolerability and meaningful reductions in disease-relevant STAT3-driven immune cell ...
Turn Therapeutics, Inc. (NASDAQ: TTRX), a clinical-stage biotechnology company developing targeted, non-systemic therapies for inflammatory skin diseases, today announced the completion of a ...
Regulatory alignment with U.S. Food and Drug Administration (FDA) on key elements of NOV-ERA Phase 2b study design, including novel primary ...
After a four-month investigation, Nature Medicine has decided to pull a viral study that linked early-day PD-1/chemo ...
ATAI completes dosing in the phase IIb Elumina study of VLS-01 for treatment-resistant depression, with top-line efficacy and ...
An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial design, one of the most difficult steps in drug development, according to a ...
Securing central venous access in neonates and infants is one of the most technically demanding tasks in pediatric anesthesia ...
The findings suggest that Covid vaccines reduced the likelihood of severe illness last fall and winter.
US Health and Human Services Secretary Robert F. Kennedy Jr. attacks scientific literature with censorship to push MAHA ...
Having sexual intercourse at an earlier age may set off a chain of biological and behavioral events that accelerates the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results